Published • loading... • Updated
Executive Change: GeneDx (Nasdaq: WGS) Appoints Mark Gardner as President
Summary by Intelligence360 News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Executive Change: GeneDx (Nasdaq: WGS) Appoints Mark Gardner as President
Stamford, CT – GeneDx has announced the appointment of Mark Gardner as President. About GeneDx: We see a world where every genetic condition is understood, and every patient receives the care they need to live their healthiest life through genomics. GeneDx combines unmatched clinical expertise, advanced technology, and the power of GeneDx Infinity, the worlds largest rare disease genomic dataset. This unparalleled foundation powers GeneDxs Exome…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
